MK-677 results claims on TikTok: what the science says

What did @coachbradleybodybuildin0 actually say?

The creator runs through a week-by-week breakdown of MK-677 at 20mg, claiming users will feel dramatic effects almost immediately. "Within the first week, your appetite goes absolutely insane," he says, followed by deep sleep and waking up "full or heavier and tighter." By week two, he claims muscles look rounder, veins are visible, and the scale is climbing. The boldest claim comes at the end: "MK-677 at 20mg is a cheat code for mass. You don't wait months, you see this shooting days." He also asserts that bones, joints, and tissue get "rebuilt overnight" and that recovery becomes machine-like. This is a fast-talking, benefit-heavy pitch with no mention of side effects, regulatory status, or the difference between water retention and actual muscle tissue growth. That omission is not a minor detail. It is the entire story.

Does the science back this up?

Partially, but the framing is doing a lot of heavy lifting. MK-677, also called ibutamoren, is a ghrelin receptor agonist that stimulates growth hormone secretion and raises IGF-1 levels. The appetite and sleep effects are real and well-documented. The claims about rebuilding bone and muscle "overnight" are not.

A randomized controlled trial by Nass et al. (2008, Annals of Internal Medicine) found that MK-677 increased lean mass and reduced fat mass in healthy older adults over two years, but the effects were modest and built gradually. A 2018 study by Svensson et al. in the Journal of Clinical Endocrinology and Metabolism confirmed GH and IGF-1 elevation, but noted that functional muscle strength did not improve proportionally. The early scale jump and visual fullness the creator describes are most likely water retention driven by elevated GH, not new contractile muscle tissue. That distinction matters enormously if someone is making training or nutrition decisions based on what they see in the mirror at day seven.

What did they get wrong (or right)?

Credit where it is due: the appetite increase is one of the most consistently reported effects of MK-677 across both clinical literature and user-reported data. Sleep quality improvements, particularly around slow-wave sleep, are also documented. Nass et al. and earlier work by Copinschi et al. (1997, Sleep) both support increased slow-wave sleep duration with MK-677 use. So the creator is not making those effects up.

What he gets wrong, significantly, is the mechanism behind early visual changes. "Muscles look rounder, skin pushed tight from water and glycogen" is actually an accurate description of what is happening, but he presents it as proof of real mass accrual rather than fluid redistribution. The phrase "rebuilt overnight" applied to bones and joints has no clinical support at any dose and no studied timeframe that resembles overnight. Bone remodeling is a process that takes months to years. Presenting water weight as transformation and fluid shifts as structural rebuilding is misleading, especially to a young audience looking for shortcuts.

He also gives no mention of known adverse effects: insulin resistance, increased fasting glucose, edema, and elevated cortisol have all been flagged in clinical studies. The Nass et al. trial reported that 39% of participants experienced edema and 23% experienced muscle pain. That is not a footnote.

What should you actually know?

MK-677 is not approved by the FDA for any indication and is not legally available as a prescription medication in the United States. It is not a scheduled controlled substance, but it occupies a legal gray area. Compounded versions exist, and some telehealth platforms operate in spaces where its use is supervised by licensed clinicians, which changes the risk profile compared to sourcing it from an unregulated supplier online.

The real concern with content like this is the dose framing. The creator states "20mg" as if it is a standard starting point anyone can follow. Clinical trials have used doses ranging from 10mg to 25mg, and even within that range, individual responses, particularly around blood glucose and cortisol, vary significantly. Anyone with pre-existing metabolic conditions, insulin sensitivity concerns, or a history of elevated IGF-1 should be especially cautious. IGF-1 elevation is not consequence-free: it is associated with cellular proliferation pathways that require context-specific evaluation by a clinician, not a TikTok video.

The bottom line is that MK-677 has a legitimate pharmacological profile that researchers have studied seriously. The creator is not entirely fabricating effects. But compressing a nuanced hormonal compound into a "cheat code" narrative with no side effect disclosure is the kind of content that sends people to unregulated sources and produces real harm.